journal article·2017-01-06Open access

Biodegradable and Biocompatible Systems Based on Hydroxyapatite Nanoparticles

Pau Turon, Luís Del Valle, Carlos Alemán, Jordi Puiggalí

Applied Sciences· Volume 7· Issue 1

Abstract

Composites of hydroxyapatite (HAp) are widely employed in biomedical applications due to their biocompatibility, bioactivity and osteoconductivity properties. In fact, the development of industrially scalable hybrids at low cost and high efficiency has a great impact, for example, on bone tissue engineering applications and even as drug delivery systems. New nanocomposites constituted by HAp nanoparticles and synthetic or natural polymers with biodegradable and biocompatible characteristics have constantly been developed and extensive works have been published concerning their applications. The present review is mainly focused on both the capability of HAp nanoparticles to encapsulate diverse compounds as well as the preparation methods of scaffolds incorporating HAp. Attention has also been paid to the recent developments on antimicrobial scaffolds, bioactive membranes, magnetic scaffolds, in vivo imaging systems, hydrogels and coatings that made use of HAp nanoparticles.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

B. Braun Surgical S.A., Carretera de Terrassa 121, Rubí 08191, Spain

Chemical Engineering Department, Escola d’Enginyeria de Barcelona Est-EEBE, c/Eduard Maristany 10-14, Barcelona 08019, Spain

References (100+)

Show source-provided references
1. Collagen-hydroxyapatite composites for hard tissue repair10.22203/eCM.v011a06 ↗
2. Calcium orthophosphate bioceramics10.1016/j.ceramint.2015.08.004 ↗
3. Calcium phosphates in biomedical applications: Materials for the future?10.1016/j.mattod.2015.10.008 ↗
4. Calcium orthophosphate-containing bionanocomposites and hybrid materials for biomedical applications10.3390/jfb6030708 ↗
5. Scaffolds for tissue fabrication10.1016/S1369-7021(04)00233-0 ↗
6. Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agents10.1002/jbm.b.31746 ↗
7. Calcium phosphate biomaterials as bone drug delivery systems: A review10.1016/j.drudis.2010.05.003 ↗
8. Multiphasic calcium orthophosphate (CaPO4) bioceramics and their biomedical applications10.1016/j.ceramint.2016.01.062 ↗
9. Crystal structure of hydroxyapatite10.1038/2041050a0 ↗
10. Characterization and reactivity of nanosized calcium phosphates prepared in anhydrous ethanol10.1021/cm00047a019 ↗
11. Pore size control in the synthesis of hydroxyapatite nanoparticles: The effect of pore expander content and the synthesis temperature10.1016/j.ceramint.2016.04.041 ↗
12. Synthesis of nanocrystalline hydroxyapatite using surfactant template systems: Role of templates in controlling morphology10.1016/j.msec.2009.05.019 ↗
13. Synthesis of mesoporous hydroxyapatite using a modified hard-templating route10.1016/j.materresbull.2009.04.014 ↗
14. Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system10.1016/j.actbio.2009.12.014 ↗
15. Block-copolymer-assisted synthesis of hydroxyapatite nanoparticles with high surface area and uniform size10.1088/1468-6996/12/4/045005 ↗
16. Fabrication and dissolution behavior of hollow hydroxyapatite microspheres intended for controlled drug release10.1016/j.materresbull.2009.06.015 ↗
17. Double emulsion droplets as microreactors for synthesis of mesoporous hydroxyapatite10.1021/cm9028935 ↗
18. Solvothermal synthesis and characterization of hierarchically nanostructured hydroxyapatite hollow spheres10.1002/ejic.200900839 ↗
19. Preparation of mesoporous hydroxyapatite films used as biomaterials via sol-gel technology10.1007/s10971-011-2601-x ↗
20. Preparation of irregular mesoporous hydroxyapatite10.1016/j.materresbull.2007.06.034 ↗
21. Synthesis of high surface area mesostructured calcium phosphate particles10.1016/j.actbio.2010.03.017 ↗
22. Fabrication of mesoporous carbonated hydroxyapatite microspheres by hydrothermal method10.1016/j.matlet.2011.04.057 ↗
23. Hydrothermal fabrication of mesoporous carbonated hydroxyapatite microspheres for a drug delivery system10.1016/j.micromeso.2012.01.037 ↗
24. Hydroxyapatite nano- and microcrystals with multiform morphologies: Controllable synthesis and luminescence properties10.1021/cg801353n ↗
25. In vitro precipitation of calcium phosphate under intracellular conditions: Formation of brushite from an amorphous precursor in the absence of ATP10.1007/BF02553710 ↗
26. Hydrothermal growth of biomimetic carbonated apatite nanoparticles with tunable size, morphology and ultrastructure10.1039/c3ce26884e ↗
27. Preparation of ultrahigh-aspect-ratio hydroxyapatite nanofibers in reverse micelles under hydrothermal conditions10.1021/la0498197 ↗
28. Nanosized hydroxyapatite precipitation from homogeneous calcium/citrate/phosphate solutions using microwave and conventional heating10.1002/(SICI)1521-4095(199801)10:1<49::AID-ADMA49>3.0.CO;2-R ↗
29. Hierarchically nanostructured hydroxyapatite: Hydrothermal synthesis, morphology control, growth mechanism, and biological activity10.2147/IJN.S29884 ↗
30. Accelerated synthesis of biomimetic nano hydroxyapatite using simulated body fluid10.1016/j.matchemphys.2016.05.060 ↗
31. Template Synthesis of gold nanoparticles with an organic molecular cage10.1021/ja412606t ↗
32. Controlling nanoparticle formation via sizable cages of supramolecular soft materials10.1021/la200196k ↗
33. Design and fabrication of a new class of nano hybrid materials based on reactive polymeric molecular cages10.1021/la4023085 ↗
34. Molecular-cage method: An improvement of the precipitation method in synthesizing nanoparticles10.1021/acs.iecr.6b01714 ↗
35. Synthesis and characterization of hydroxyapatite/chitosan nanocomposite materials for medical engineering applications10.1016/j.compositesb.2012.01.056 ↗
36. Preparation and microstructure analysis of chitosan/hydroxyapatite nanocomposites10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F ↗
37. Grafting polymerization of l-lactide on the surface of hydroxyapatite nanoparticles
38. Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate polymers science, on the chitin bicentennial10.1016/j.carbpol.2011.09.063 ↗
39. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications10.1016/S0939-6411(03)00160-7 ↗
40. Extraction and characterization of chitin and chitosan with antimicrobial and antioxidant activities from cosmopolitan Orthoptera species (Insecta)10.1007/s12257-014-0391-z ↗
41. New chitin, chitosan, and O-carboxymethyl chitosan sources from resting eggs of Daphnia longispina (Crustacea); with physicochemical characterization, and antimicrobial and antioxidant activities10.1007/s12257-013-0488-9 ↗
42. Properties and biocompatibility of chitosan films modified by blending with PVA and chemically crosslinked10.1007/s10856-008-3627-7 ↗
43. The effect of carboxymethyl-chitosan on the precipitation of calcium carbonate10.1016/j.jcrysgro.2003.03.001 ↗
44. Chitosan and carboxymethyl-chitosan capping ligands: Effects on the nucleation and growth of hydroxyapatite nanoparticles for producing biocomposite membranes10.1016/j.msec.2015.10.018 ↗
45. Nanohydroxyapatite—Calcium fructoborate composites: Synthesis and characterization
46. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells10.1016/j.injury.2011.06.014 ↗
47. Synthesis and biocompatibility evaluation of cellulose/hydroxyapatite nanocomposite scaffold in 1-n-allyl-3-methyl imidazolium chloride10.1016/j.msec.2011.02.021 ↗
48. Biomimetic design of a bacterial cellulose/hydroxyapatite nanocomposite for bone healing applications10.1016/j.msec.2009.10.007 ↗
49. Structure and properties of hydroxyapatite/cellulose nanocomposite films10.1016/j.carbpol.2011.11.029 ↗
50. Production of hydroxyapatite–bacterial cellulose nanocomposites from agroindustrial wastes10.1007/s10570-015-0734-8 ↗
51. Cost-effective production of bacterial cellulose in static cultures using distillery wastewater10.1016/j.jbiosc.2012.09.014 ↗
52. Electrospinning process and applications of electrospun fibers10.1016/0304-3886(95)00041-8 ↗
53. Tailored nanofiber morphologies using modulated electrospinning for biomedical applications
54. Colloid-electrospinning: Fabrication of multicompartment nanofibers by the electrospinning of organic or/and inorganic dispersions and emulsions10.1002/marc.201200549 ↗
55. On the way to clean and safe electrospinning-green electrospinning: Emulsion and suspension electrospinning10.1002/pat.1883 ↗
56. Conducive 3D porous mesh of poly(ε-caprolactone) made via emulsion electrospinning10.1016/j.polymer.2014.06.067 ↗
57. Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application10.1016/j.actbio.2009.05.023 ↗
58. Electrospun hydroxyapatite grafted poly(l-lactide)/poly(lactic-co-glycolic acid) nanofibers for guided bone regeneration membrane10.1016/j.compscitech.2013.02.014 ↗
59. Electrospinning PTMC/Gt/OA-HA composite fiber scaffolds and the biocompatibility with mandibular condylar chondrocytes10.1016/j.colsurfa.2016.04.007 ↗
60. Nanofibrous poly(lactic acid)/hydroxyapatite composite scaffolds for guided tissue regeneration10.1002/mabi.200700107 ↗
61. Polylactide nanofibers with hydroxyapatite as growth substrates for osteoblast-like cells10.1002/jbm.a.35061 ↗
62. Microarray-based gene expression analysis of human osteoblasts in response to different biomaterials
63. Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1beta and cyclooxygenase-2 mRNA in human breast cancer cell lines10.1023/A:1023908307108 ↗
64. Electrospun polyvinyl alcohol-collagen-hydroxyapatite nanofibers: A biomimetic extracellular matrix for osteoblastic cells10.1088/0957-4484/23/11/115101 ↗
65. Hydrothermal fabrication of hydroxyapatite/chitosan/carbon porous scaffolds for bone tissue engineering10.1002/jbm.b.33151 ↗
66. Nanostructured Biomaterials from Electrospun Demineralized Bone-Matrix: A Survey of Processing and Crosslinking Strategies10.1021/am501700e ↗
67. Biointerface control of electrospun fiber scaffolds for bone regeneration: Engineered protein link to mineralized surface10.1016/j.actbio.2014.01.021 ↗
68. Calcium phosphate deposition rate, structure and osteoconductivity on electrospun poly(l-lactic acid) matrix using electrodeposition or simulated body fluid incubation10.1016/j.actbio.2013.08.041 ↗
69. Understanding biofilm resistance to antibacterial agents10.1038/nrd1008 ↗
70. Muñoz-Bonilla, A., Cerrada, M.L., and Fernández-García, M. (2013). Polymeric Materials with Antimicrobial Activity, RSC Polymer Chemistry Series. Chapter 6.10.1039/9781782624998 ↗
71. Resistance profiles in surgical-site infection10.2217/17460913.3.4.453 ↗
72. Surgical site infections: How high are the costs?10.1016/j.jhin.2009.03.020 ↗
73. Infections related to medical devices10.7326/0003-4819-89-5-764 ↗
74. Antibiotic-eluting medical devices for various applications10.1016/j.jconrel.2008.05.020 ↗
75. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement10.1016/j.biomaterials.2006.03.032 ↗
76. Interaction of silver(I) ions with the respiratory chain of Escherichia coli: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+10.1021/bi0508542 ↗
77. Effect of silver ions on transport and retention of phosphate by Escherichia coli10.1128/jb.152.1.7-13.1982 ↗
78. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA10.1088/0957-4484/20/8/085102 ↗
79. Antimicrobial effects of silver nanoparticles10.1016/j.nano.2006.12.001 ↗
80. Antibacterial nanosized silver substituted hydroxyapatite: Synthesis and characterization10.1002/jbm.a.30958 ↗
81. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite10.1023/A:1008811501734 ↗
82. Development of nanosized silver-substituted apatite for biomedical applications: A review10.1016/j.nano.2015.03.016 ↗
83. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections10.1016/j.biomaterials.2004.06.045 ↗
84. One-step synthesis of silver nanoparticle-decorated hydroxyapatite nanowires for the construction of highly flexible free-standing paper with high antibacterial activity10.1002/chem.201601438 ↗
85. Copper(II), zinc(II) and copper(II)/zinc(II)-containing carbonate-substituted hydroxyapatite: Synthesis, characterization and thermal behaviour10.1002/mawe.201600460 ↗
86. Copper substituted hydroxyapatite and fluorapatite; Synthesis, characterization and antimicrobial properties10.1016/j.ceramint.2014.07.086 ↗
87. Controlled synthesis of luminescent F-substituted strontium hydroxyapatite with hierarchical structures for drug delivery10.1039/c1ce06265d ↗
88. Facile synthesis of an up-conversion luminescent and mesoporous Gd2O3: Er3+@nSiO2@mSiO2 nanocomposite as a drug carrier10.1039/C0NR00695E ↗
89. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent10.1039/c2nr30425b ↗
90. A general strategy for nanocrystal synthesis10.1038/nature03968 ↗
91. Fabrication of luminescent hydroxyapatite nanorods through surface-initiated RAFT polymerization: Characterization, biological imaging and drug delivery applications10.1016/j.apsusc.2016.05.157 ↗
92. Hydroxyapatite nanocrystals: Colloidal chemistry, assembly and their biological applications10.1039/C3QI00087G ↗
93. Fluoridated HAp:Ln3+ (Ln = Eu or Tb) nanoparticles for cell-imaging10.1039/c2nr32404k ↗
94. Ln3+-doped hydroxyapatite nanocrystals: Controllable synthesis and cell imaging10.1039/C5CP01845E ↗
95. PEGylation of fluoridated hydroxyapatite (FAp): Ln3+ nanorods for cell imaging10.1039/c3py00489a ↗
96. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals10.1016/j.biomaterials.2007.10.051 ↗
97. Polymeric AIE-based nanoprobes for biomedical applications: Recent advances and perspectives10.1039/C5NR01444A ↗
98. AIE luminogen bridged hollow hydroxyapatite nanocapsules for drug delivery10.1039/c3dt50243k ↗
99. Nanoparticles as contrast agents for in vivo bioimaging: Current status and future perspectives10.1007/s00216-010-4207-5 ↗
100. Applications of magnetic nanoparticles in biomedicine10.1088/0022-3727/36/13/201 ↗